Search the Newsreel

Outset (OM) Results at a Glance: Reported EPS Misses Expectations at the Close; Session Move: The Stock Ends Down 1.05% in the Latest Reading - Earnings Manipulation Risk

Outset Medical CFO Renee Gaeta sells $19,943 in stock

Renee Gaeta, CFO of Outset Medical (NASDAQ: OM), sold 4,543 shares of company stock worth $19,943 on August 17, 2026. This transaction was a "sell to cover" to satisfy tax obligations related to vested Restricted Stock Units, not a discretionary trade. The sale occurred …

Outset Medical CEO Leslie Trigg sells $15,088 in shares By Investing.com

Outset Medical CEO Leslie Trigg sold 3,437 shares of the company's common stock for $15,088. This transaction was identified as a "sell to cover" to satisfy tax withholding obligations related to the vesting of restricted stock units. Following the sale, Trigg directly and indirectly …

OM | Outset Medical, Inc. Common Financials - Revenue Breakdown

Outset Medical general counsel sells $11,554 in stock

John L. Brottem, General Counsel at Outset Medical, Inc. (NASDAQ:OM), sold 2,632 shares of common stock for $11,554 on August 17, 2026. This "sell to cover" transaction was to fulfill tax withholding obligations related to vested Restricted Stock Units, not a discretionary trade. The …

Insider Selling: Outset Medical (NASDAQ:OM) General Counsel Sells $11,554.48 in Stock

Outset Medical's General Counsel, John Brottem, sold 2,632 shares of OM stock for $11,554.48 to cover tax obligations from vested equity awards, reducing his direct ownership by 2.92%. This sale occurred as OM shares dropped 7.3% to $4.18, and the company reported a quarterly …

Outset Medical (OM) counsel sells shares to cover taxes

Outset Medical (OM) General Counsel John L. Brottem sold 2,632 shares of common stock at $4.39 per share on August 17, 2026. This "sell to cover" transaction was non-discretionary and intended to satisfy tax withholding obligations from the vesting of 5,033 RSU-based shares granted …

Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock

Outset Medical (OM) insider Leslie Trigg plans NASDAQ sale of 3,344 shares

Outset Medical (OM) insider Leslie Trigg has filed a notice for the proposed sale of 3,344 shares of common stock on NASDAQ, with an estimated market value of $15,079.88, scheduled for on or after August 17, 2026. These shares are part of the settlement …

Outset Medical (NASDAQ:OM) Raised to Hold at Wall Street Zen

Wall Street Zen upgraded Outset Medical (NASDAQ:OM) from "Sell" to "Hold," leading to a 6.1% increase in its stock price. Despite reporting revenue above estimates, the company posted a larger-than-expected adjusted loss. Outset Medical continues to face financial challenges, marked by negative net margins …

Outset Medical (OM) insider files to sell shares and settle RSUs

Outset Medical (OM) insider John Brottem has filed a Form 144 to sell 2,562 shares of common stock through Morgan Stanley Smith Barney LLC on August 17, 2026, with an aggregate market value of $11,549.17. The filing also indicates the settlement of 5,033 vested …

Outset Medical, Inc. (NASDAQ:OM) Given Average Recommendation of "Hold" by Analysts

Analysts have issued an average "Hold" recommendation for Outset Medical, Inc. (NASDAQ:OM), with a consensus 12-month price target of $10.00, significantly above its current trading price of $4.50. The company recently reported a quarterly loss of $0.80 per share, missing estimates, though revenue exceeded …

AQR Capital discloses 5.39% Outset Medical (OM) ownership in Schedule 13G

AQR Capital Management Holdings, LLC and its subsidiary AQR Capital Management, LLC have disclosed a 5.39% beneficial ownership in Outset Medical, Inc. (OM), according to a Schedule 13G filing. The entities collectively own 998,961 shares of common stock, demonstrating shared voting power over 966,795 …

Bank of America (OM) reports 3.5% beneficial stake in Outset Medical shares

Bank of America Corporation has reported a beneficial ownership of 3.5% in Outset Medical, Inc., holding 666,596 shares of common stock. This stake, representing a shared voting and dispositive power, is held through several of its wholly-owned subsidiaries. The filing indicates that Bank of …

Outset Medical Number of Employees 2026 | Employee Count & Headcount Data

Outset Medical, Inc. (NASDAQ: OM) had 308 employees worldwide as of March 2026, representing a 33.2% decline from 2023. The company is actively hiring, with 53 job postings in 2026. Its workforce is primarily in North America (67.5%), and the average salary is $112,809.

Osisko Metals (TSX:OM) Is Up 20.8% After Reporting Deepening 2026 Losses Has The Bull Case Changed?

Osisko Metals Incorporated reported second-quarter 2026 results showing a net loss of C$84.13 million, versus net income of C$0.796 million in the same period a year earlier, with basic and diluted loss per share from continuing operations of C$0.11. Over the first six months …

Outset Medical, Inc. Q2 2026: Revenue $31.6M, EPS $(0.97) — 10-Q Summary

Outset Medical, Inc. reported its Q2 2026 results, showing essentially flat revenue year-over-year at $31.6M and an improved net loss of $18M, with diluted EPS at $(0.97). The company is focusing on accelerating acute care adoption and expanding into new markets, while gross margin …

Outset Medical Reports Second Quarter 2026 Results

Outset Medical, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting net revenue of $31.6 million, a 1% increase year-over-year, and a gross margin expansion to 42%. The company highlighted a three-year, $40 million agreement with HCA Healthcare and …

Outset Medical (NASDAQ:OM) Issues Quarterly Earnings Results

Outset Medical earnings missed by $0.05, revenue topped estimates

Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates

Outset Medical, Inc. (OM) reported a Q2 loss of $0.8 per share, which was wider than the Zacks Consensus Estimate of a $0.63 loss. However, the company surpassed revenue estimates, posting $31.64 million for the quarter, exceeding the consensus by 9.84%. Despite the earnings …

Outset Medical (OM) Stock Falls on Q2 2026 Earnings

Outset Medical (OM) reported Q2 2026 revenue of $31.6 million, exceeding analyst expectations, but its stock fell 3.4% after market close due to a widened operating loss and a larger-than-estimated net loss per share. Insider activity shows significant selling, while institutional investors present a …

Earnings call transcript: Outset Medical posts mixed Q2 2026 results, shares edge up

Outset Medical reported mixed Q2 2026 results, with revenue slightly exceeding expectations at $31.6 million but an adjusted loss per share of $0.80, wider than the anticipated $0.75. Shares saw a modest increase of 0.96% in after-hours trading. The company reiterated its full-year 2026 …

[10-Q] Outset Medical, Inc. Quarterly Earnings Report

Outset Medical Inc. (OM) Misses Q2 EPS by 5c

Outset Medical Inc. (OM) reported its Q2 earnings, missing analyst estimates for EPS by $0.05, with an EPS of ($0.80) against an anticipated ($0.75). Despite the EPS miss, the company slightly exceeded revenue expectations, bringing in $31.6 million compared to the consensus estimate of …

Outset Medical (OM) Rallies 1.95% as Shares Hold Above $4.96 Support - Long Setup Ideas

OM ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 6, 2022 in the Class Action Filed on Behalf of Outset Medical, Inc. Limited Shareholders

The Klein Law Firm has announced a lead plaintiff deadline of September 6, 2022, for a class action lawsuit filed against Outset Medical, Inc. (NASDAQ: OM). The lawsuit alleges that Outset Medical made materially false or misleading statements regarding its Tablo Hemodialysis System, specifically …

Outset Medical Inc (OM) Institutional Confidence

Outset Medical Inc (OM) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 98.04%, a slight decrease from the previous quarter. James Simons is the largest institutional shareholder, holding 1.20% of …

Outset Medical (OM) Expected to Post Earnings on Thursday

BlackRock (OM) updates Outset Medical ownership, reporting 365,556 shares and 2.0%

BlackRock, Inc. has filed an amended Schedule 13G, disclosing its beneficial ownership of 365,556 shares of Outset Medical, Inc. common stock, which represents 2.0% of the outstanding class. The filing indicates BlackRock holds sole voting and dispositive power over these shares, with no shared …

Law firm investigates Outset Medical officers f...

Halper Sadeh LLC is investigating whether certain officers and directors of Outset Medical, Inc. breached their fiduciary duties to shareholders. The law firm is offering to handle claims on a contingent fee basis, meaning shareholders will not incur upfront legal costs. This investigation aims …

Outset Medical Inc (OM) Cash Flow

This article provides a detailed cash flow statement for Outset Medical Inc (OM), presenting quarterly and annual figures for operating, investing, and financing activities. It includes year-over-year changes for various cash flow components and explains key financial terms like operating cash flow, investing cash …

OM|Outset Medical Inc|Price:4.040|Chg%:-0.190

Outset Medical Inc. (OM) is a medical technology company specializing in the Tablo Hemodialysis System, a comprehensive solution for dialysis delivery. The system integrates water purification and on-demand dialysate production. The article outlines the company's background, financial data, key executives, and institutional shareholding information.